Home/Filings/4/0001179110-16-018642
4//SEC Filing

Blueprint Medicines Corp 4

Accession 0001179110-16-018642

CIK 0001597264operating

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 4:15 PM ET

Size

5.3 KB

Accession

0001179110-16-018642

Insider Transaction Report

Form 4
Period: 2016-02-03
Lengauer Christoph
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2016-02-03+40,000178,179 total
    Exercise: $15.01Exp: 2026-02-03Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]This option vests with respect to 1/48th of the shares underlying the option on March 3, 2016 and as to an additional 1/48th of the shares underlying the option each month thereafter.

Issuer

Blueprint Medicines Corp

CIK 0001597264

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001597264

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:15 PM ET
Size
5.3 KB